For stomach adenocarcinoma (STAD), the results are similar to those of the liver; the ACHE gene is overexpressed in the primary tumor, and the increase is significant in stages 2 and 3 (Figure 6E). This evidence concerns the gene ACHE and gastric adenocarcinoma.